Volume 68 Received 27 October 2012 | |||||||||||
| |||||||||||
aScience and Engineering Faculty, Queensland University of Technology, GPO Box 2434, Brisbane, Queensland 4001, Australia
Correspondence e-mail: g.smith@qut.edu.au
The title compound, C17H16Br2O3, which is a restricted commercial acaricide (common name bromopropylate), has two independent and conformationally similar molecules in the asymmetric unit [dihedral angles between the planes of the two phenyl rings = 68.7 (4) and 77.4 (5)°]. The C atoms of the isopropyl group of one of the molecules are disordered over two sites with occupancies of 0.638 (16) and 0.362 (16). Minor non-merohedral twinning was also present in the crystal. Intermolecular O-H
O hydrogen-bonding interactions involving the hydroxy groups and carboxyl O-atom acceptors give separate centrosymmetric homodimers through cyclic hydrogen-bonding motifs [graph set R22(10)].
For background information on bromopropylate, see: O'Neil (2001
). For the structures of benzilic acid and an analogous benzilate ester, see: Qui et al. (2007
); Fu et al. (2006
). For graph-set analysis, see: Etter et al. (1990
).
|
|
| ||||||||||||||||||||||
Data collection: CrysAlis PRO (Agilent, 2012
); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SIR92 (Altomare et al., 1993
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
) within WinGX (Farrugia, 1999
); molecular graphics: PLATON (Spek, 2009
); software used to prepare material for publication: PLATON.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SJ5277 ).
The author acknowledges financial support from the Australian Research Council and the Science and Engineering Faculty and the University Library, Queensland University of Technology.
Agilent (2012). CrysAlis PRO. Agilent Technologies Ltd, Yarnton, England.
Altomare, A., Cascarano, G., Giacovazzo, C. & Guagliardi, A. (1993). J. Appl. Cryst. 26, 343-350.
![[details]](../../../../../../j/graphics/details.gif)
Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256-262.
![[details]](../../../../../../b/graphics/details.gif)
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.
![[details]](../../../../../../j/graphics/details.gif)
Fu, D.-C., Sun, F.-X., Liu, Q. & Lv, H.-J. (2006). Acta Cryst. E62, o5284-o5285.
![[details]](../../../../../../e/graphics/details.gif)
O'Neil, M. C. (2001). The Merck Index, 13th ed., p. 239. Whitehouse Station, NJ, USA: Merck & Co. Inc.
Qui, Y., Wang, K., Liu, Y., Deng, H., Sun, F. & Cai, Y. (2007). Inorg. Chim. Acta, 360, 1819-1824.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)